Abe K, Toba M, Alzoubi A, Koubsky K, Ito M, Ota H, Gairhe S, Gerthoffer WT, Fagan KA, McMurtry IF, Oka M (2011) Tyrosine kinase inhibitors are potent acute pulmonary vasodilators in rats. Am J Respir Cell Mol Biol 45:804–808. https://doi.org/10.1165/rcmb.2010-0371OC

Article  CAS  Google Scholar 

Amado-Azevedo J, van Stalborch AD, Valent ET, Nawaz K, van Bezu J, Eringa EC, Hoevenaars FPM, De Cuyper IM, Hordijk PL, van Hinsbergh VWM, van Nieuw Amerongen GP, Aman J, Margadant C (2021) Depletion of Arg/Abl2 improves endothelial cell adhesion and prevents vascular leak during inflammation. Angiogenesis 24:677–693. https://doi.org/10.1007/s10456-021-09781-x

Article  CAS  Google Scholar 

Aman J, van Bezu J, Damanafshan A, Huveneers S, Eringa EC, Vogel SM, Groeneveld AB, Vonk Noordegraaf A, van Hinsbergh VW, van Nieuw Amerongen GP (2012) Effective treatment of edema and endothelial barrier dysfunction with imatinib. Circulation 126:2728–2738. https://doi.org/10.1161/circulationaha.112.134304

Article  CAS  Google Scholar 

Attwood MM, Fabbro D, Sokolov AV, Knapp S, Schiöth HB (2021) Trends in kinase drug discovery: targets, indications and inhibitor design. Nat Rev Drug Discov 20:839–861. https://doi.org/10.1038/s41573-021-00252-y

Article  CAS  Google Scholar 

Beijnink CWH, van der Hoeven NW, Konijnenberg LSF, Kim RJ, Bekkers S, Kloner RA, Everaars H, El Messaoudi S, van Rossum AC, van Royen N, Nijveldt R (2021) Cardiac MRI to visualize myocardial damage after ST-segment elevation myocardial infarction: a review of its histologic validation. Radiology 301:4–18. https://doi.org/10.1148/radiol.2021204265

Article  Google Scholar 

Betgem RP, de Waard GA, Nijveldt R, Beek AM, Escaned J, van Royen N (2015) Intramyocardial haemorrhage after acute myocardial infarction. Nat Rev Cardiol 12:156–167. https://doi.org/10.1038/nrcardio.2014.188

Article  Google Scholar 

Bøtker HE, Hausenloy D, Andreadou I, Antonucci S, Boengler K, Davidson SM, Deshwal S, Devaux Y, Di Lisa F, Di Sante M, Efentakis P, Femminò S, García-Dorado D, Giricz Z, Ibanez B, Iliodromitis E, Kaludercic N, Kleinbongard P, Neuhäuser M, Ovize M, Pagliaro P, Rahbek-Schmidt M, Ruiz-Meana M, Schlüter KD, Schulz R, Skyschally A, Wilder C, Yellon DM, Ferdinandy P, Heusch G (2018) Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection. Basic Res Cardiol 113:39. https://doi.org/10.1007/s00395-018-0696-8

Article  CAS  Google Scholar 

Bouitbir J, Panajatovic MV, Krähenbühl S (2022) Mitochondrial toxicity associated with imatinib and sorafenib in isolated rat heart fibers and the cardiomyoblast H9c2 cell line. Int J Mol Sci. https://doi.org/10.3390/ijms23042282

Article  Google Scholar 

Chislock EM, Pendergast AM (2013) Abl family kinases regulate endothelial barrier function in vitro and in mice. PLoS ONE 8:e85231. https://doi.org/10.1371/journal.pone.0085231

Article  CAS  Google Scholar 

de Waha S, Patel MR, Granger CB, Ohman EM, Maehara A, Eitel I, Ben-Yehuda O, Jenkins P, Thiele H, Stone GW (2017) Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials. Eur Heart J 38:3502–3510. https://doi.org/10.1093/eurheartj/ehx414

Article  CAS  Google Scholar 

Dejana E, Orsenigo F, Lampugnani MG (2008) The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 121:2115–2122. https://doi.org/10.1242/jcs.017897

Article  CAS  Google Scholar 

Desmet W, Bogaert J, Dubois C, Sinnaeve P, Adriaenssens T, Pappas C, Ganame J, Dymarkowski S, Janssens S, Belmans A, Van de Werf F (2011) High-dose intracoronary adenosine for myocardial salvage in patients with acute ST-segment elevation myocardial infarction. Eur Heart J 32:867–877. https://doi.org/10.1093/eurheartj/ehq492

Article  CAS  Google Scholar 

Druker BJ, Guilhot F, O’Brien SG, Gathmann I, Kantarjian H, Gattermann N, Deininger MW, Silver RT, Goldman JM, Stone RM, Cervantes F, Hochhaus A, Powell BL, Gabrilove JL, Rousselot P, Reiffers J, Cornelissen JJ, Hughes T, Agis H, Fischer T, Verhoef G, Shepherd J, Saglio G, Gratwohl A, Nielsen JL, Radich JP, Simonsson B, Taylor K, Baccarani M, So C, Letvak L, Larson RA (2006) Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 355:2408–2417. https://doi.org/10.1056/NEJMoa062867

Article  CAS  Google Scholar 

Duijvelaar E, Vanhove A, Schippers JR, Smeele PJ, de Man FS, Pinto Y, Aman J, Bogaard HJ (2022) Cardiac safety of imatinib for the treatment of Covid-19: a secondary analysis of a randomised, double blind, placebo-controlled trial. J Cardiovasc Pharmacol. https://doi.org/10.1097/fjc.0000000000001344

Article  Google Scholar 

Eitel I, Stiermaier T, Lange T, Rommel KP, Koschalka A, Kowallick JT, Lotz J, Kutty S, Gutberlet M, Hasenfuß G, Thiele H, Schuster A (2018) Cardiac magnetic resonance myocardial feature tracking for optimized prediction of cardiovascular events following myocardial infarction. JACC Cardiovasc Imaging 11:1433–1444. https://doi.org/10.1016/j.jcmg.2017.11.034

Article  Google Scholar 

Fazakas C, Nagaraj C, Zabini D, Végh AG, Marsh LM, Wilhelm I, Krizbai IA, Olschewski H, Olschewski A, Bálint Z (2018) Rho-kinase inhibition ameliorates dasatinib-induced endothelial dysfunction and pulmonary hypertension. Front Physiol 9:537. https://doi.org/10.3389/fphys.2018.00537

Article  Google Scholar 

Galaup A, Gomez E, Souktani R, Durand M, Cazes A, Monnot C, Teillon J, Le Jan S, Bouleti C, Briois G, Philippe J, Pons S, Martin V, Assaly R, Bonnin P, Ratajczak P, Janin A, Thurston G, Valenzuela DM, Murphy AJ, Yancopoulos GD, Tissier R, Berdeaux A, Ghaleh B, Germain S (2012) Protection against myocardial infarction and no-reflow through preservation of vascular integrity by angiopoietin-like 4. Circulation 125:140–149. https://doi.org/10.1161/circulationaha.111.049072

Article  CAS  Google Scholar 

Hamid T, Xu Y, Ismahil MA, Rokosh G, Jinno M, Zhou G, Wang Q, Prabhu SD (2022) Cardiac mesenchymal stem cells promote fibrosis and remodeling in heart failure: role of PDGF signaling. JACC Basic Transl Sci 7:465–483. https://doi.org/10.1016/j.jacbts.2022.01.004

Article  Google Scholar 

Hausenloy DJ, Chilian W, Crea F, Davidson SM, Ferdinandy P, Garcia-Dorado D, van Royen N, Schulz R, Heusch G (2019) The coronary circulation in acute myocardial ischaemia/reperfusion injury: a target for cardioprotection. Cardiovasc Res 115:1143–1155. https://doi.org/10.1093/cvr/cvy286

Article  CAS  Google Scholar 

Heusch G (2016) The coronary circulation as a target of cardioprotection. Circ Res 118:1643–1658. https://doi.org/10.1161/circresaha.116.308640

Article  CAS  Google Scholar 

Heusch G (2020) Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nat Rev Cardiol 17:773–789. https://doi.org/10.1038/s41569-020-0403-y

Article  Google Scholar 

Heusch G, Gersh BJ (2017) The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. Eur Heart J 38:774–784. https://doi.org/10.1093/eurheartj/ehw224

Article  CAS  Google Scholar 

Hollander MR, de Waard GA, Konijnenberg LS, Meijer-van Putten RM, van den Brom CE, Paauw N, de Vries HE, van de Ven PM, Aman J, Van Nieuw-Amerongen GP, Hordijk PL, Niessen HW, Horrevoets AJ, Van Royen N (2016) Dissecting the effects of ischemia and reperfusion on the coronary microcirculation in a rat model of acute myocardial infarction. PLoS ONE 11:e0157233. https://doi.org/10.1371/journal.pone.0157233

Article  CAS  Google Scholar 

Hui KP, Cheung MC, Lai KL, Ng KC, Ho JC, Peiris M, Nicholls JM, Chan MC (2022) Role of epithelial-endothelial cell interaction in the pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Clin Infect Dis 74:199–209. https://doi.org/10.1093/cid/ciab406

Article  CAS  Google Scholar 

Jernberg T, Johanson P, Held C, Svennblad B, Lindbäck J, Wallentin L (2011) Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction. JAMA 305:1677–1684. https://doi.org/10.1001/jama.2011.522

Article  CAS  Google Scholar 

Kerkelä R, Grazette L, Yacobi R, Iliescu C, Patten R, Beahm C, Walters B, Shevtsov S, Pesant S, Clubb FJ, Rosenzweig A, Salomon RN, Van Etten RA, Alroy J, Durand JB, Force T (2006) Cardiotoxicity of the cancer therapeutic agent imatinib mesylate. Nat Med 12:908–916. https://doi.org/10.1038/nm1446

Article  CAS  Google Scholar 

Kheifets M, Vaknin-Assa H, Greenberg G, Orvin K, Assali A, Kornowski R, Perl L (2022) Trends in ST-elevation myocardial infarction. Coron Artery Dis 31:1–8. https://doi.org/10.1097/mca.0000000000001058

Article  Google Scholar 

Kleinbongard P, Andreadou I, Vilahur G (2021) The platelet paradox of injury versus protection in myocardial infarction-has it been overlooked? Basic Res Cardiol 116:37. https://doi.org/10.1007/s00395-021-00876-6

Article  Google Scholar 

Kleinbongard P, Heusch G (2022) A fresh look at coronary microembolization. Nat Rev Cardiol 19:265–280. https://doi.org/10.1038/s41569-021-00632-2

Article  Google Scholar 

Kobara M, Nessa N, Toba H, Nakata T (2021) Induction of autophagy has protective roles in imatinib-induced cardiotoxicity. Toxicol Rep 8:1087–1097. https://doi.org/10.1016/j.toxrep.2021.05.008

Article  CAS  Google Scholar 

Kogata N, Arai Y, Pearson JT, Hashimoto K, Hidaka K, Koyama T, Somekawa S, Nakaoka Y, Ogawa M, Adams RH, Okada M, Mochizuki N (2006) Cardiac ischemia activates vascular endothelial cadherin promoter in both preexisting vascular cells and bone marrow cells involved in neovascularization. Circ Res 98:897–904. https://doi.org/10.1161/01.RES.0000218193.51136.ad

Article  CAS  Google Scholar 

Konijnenberg LSF, Damman P, Duncker DJ, Kloner RA, Nijveldt R, van Geuns RM, Berry C, Riksen NP, Escaned J, van Royen N (2020) Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction. Cardiovasc Res 116:787–805. https://doi.org/10.1093/cvr/cvz301

Article  CAS  Google Scholar 

Koning NJ, de Lange F, van Meurs M, Jongman RM, Ahmed Y, Schwarte LA, van Nieuw Amerongen GP, Vonk ABA, Niessen HW, Baufreton C, Boer C (2018) Reduction of vascular leakage by imatinib is associated with preserved microcirculatory perfusion and reduced renal injury markers in a rat model of cardiopulmonary bypass. Br J Anaesth 120:1165–1175. https://doi.org/10.1016/j.bja.2017.11.095

Article  CAS  Google Scholar 

Li Y, Yao Y, Li J, Chen Q, Zhang L, Wang QK (2019) Losartan protects against myocardial ischemia and reperfusion injury via vascular integrity preservation. Faseb j 33:8555–8564. https://doi.org/10.1096/fj.201900060R

Article  CAS  Google Scholar 

Lieder HR, Tsoumani M, Andreadou I, Schrör K, Heusch G, Kleinbongard P (2022) Platelet-mediated transfer of cardioprotection by remote ischemic conditioning and its abrogation by aspirin but not by ticagrelor. Cardiovasc Drugs Ther. https://doi.org/10.1007/s10557-022-07345-9

Article  Google Scholar 

Liu T, Howarth AG, Chen Y, Nair AR, Yang HJ, Ren D, Tang R, Sykes J, Kovacs MS, Dey D, Slomka P, Wood JC, Finney R, Zeng M, Prato FS, Francis J, Berman DS, Shah PK, Kumar A, Dharmakumar R (2022) Intramyocardial hemorrhage and the “wave front” of reperfusion injury compromising myocardial salvage. J Am Coll Cardiol 79:35–48. https://doi.org/10.1016/j.jacc.2021.10.034

Article  Google Scholar 

Magruder JT, Grimm JC, Crawford TC, Johnston L, Santhanam L, Stephens RS, Berkowitz DE, Shah AS, Bush EL, Damarla M, Damico RL, Hassoun PM, Kim BS (2018) Imatinib is protective against ischemia-reperfusion injury in an ex vivo rabbit model of lung injury. Ann Thorac Surg 105:950–956. https://doi.org/10.1016/j.athoracsur.2017.10.002

Article  Google Scholar 

McMullen CJ, Chalmers S, Wood R, Cunningham MR, Currie S (2020) Sunitinib and imatinib display differential cardiotoxicity in adult rat cardiac fibroblasts that involves a role for calcium/calmodulin dependent protein kinase II. Front